Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-22 Option Award | 2024-01-23 4:15 pm | N/A 2034-01-22 | Indaptus Therapeutics Inc. | INDP | Sassi Nir Chief Financial Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-01-18 Option Award | 2023-01-20 4:05 pm | N/A 2033-01-18 | Indaptus Therapeutics Inc. | INDP | Sassi Nir Chief Financial Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-02-25 Option Award | 2022-02-28 4:30 pm | N/A 2032-02-25 | Indaptus Therapeutics Inc. | INDP | Sassi Nir Chief Financial Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-08-04 Option Award | 2021-08-06 5:00 pm | N/A 2026-08-04 | Indaptus Therapeutics Inc. | INDP | Sassi Nir Chief Financial Officer | 35,000 | $0 | 35,000 (Direct) | View |
Ownership | 2021-08-02 4:45 pm | N/A 2026-03-27 | Intec Parent Inc. | NTEC | Sassi Nir Chief Financial Officer | 0 | $0 | 8,291 (Direct) | View |
| 2020-09-16 Option Award | 2020-09-18 5:02 pm | N/A 2027-09-16 | Intec Pharma Ltd. | NTEC | Sassi Nir Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2020-02-17 Option Award | 2020-02-19 9:46 pm | N/A 2027-02-17 | Intec Pharma Ltd. | NTEC | Sassi Nir Chief Financial Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2019-09-13 Option Award | 2019-09-16 9:32 pm | N/A 2026-09-13 | Intec Pharma Ltd. | NTEC | Sassi Nir Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |